StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Workforce dynamics by Year

Workforce dynamics — Annual new hires (employees)

Vertex Pharmaceuticals Workforce dynamics: 12.00 employees in FY2025, up 100.0% from a year earlier.

Latest, FY2025
12.00
Period ended Dec 31, 2025
Change on a year earlier
+100.0%
6.00 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Where the FY2025 figure comes from

“New Hires Globally (approximate) 900 1,100 1,100 Voluntary Turnover Rate (Global, Trailing 12 Months Metric) 5.6% 4.4% 4.7%”

Source: Vertex Corporate Responsibility / ESG Report (2025-Vertex-Data-Summary.pdf) ↗

Reported in Vertex Corporate Responsibility & Data Summary Reports.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Vertex Pharmaceuticals Workforce dynamics, annual FY2022–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/esg-new-hires

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.